Call (704)-333-7376 Are You a New Patient/Provider?
Click Here Are You a Current Patient/Provider?

Archive for category: Cancer Treatments

You are here: Home / Blog / Cancer Treatments

Video: What to Expect During Radiation Oncology Treatment

The Levine Cancer Institute, working hand in hand with Southeast Radiation Oncology Group, provides comprehensive care with a focus on empowering and educating patients . With this purpose, Dr. Sharp…

SERO Offers the SpaceOAR System for Prostate Cancer Treatment

SERO Offers the SpaceOAR System for Prostate Cancer Treatment Written by: SERO Staff Prostate cancer has a high survival rate, but seeking treatment is not always an easy decision to make when it comes…

Dr. Heinzerling Presents His Research at the OncLive State of the Science Summit

Dr. Heinzerling Presents His Research at the OncLive State of the Science Summit Written by: SERO Staff Dr. Heinzerling presented on the topic of Advanced Non-Small Cell Lung Cancer at the OncLive…

Types of Immunotherapy

Immunotherapy refers to a type of cancer treatment that attempts to stimulate the body's immune system to attack and kill cancer cells. The immune system is the body's natural defense against germs and disease. The main components of the immune system are the organs, tissues, and fluids that make up the lymph system—including white blood cells. White blood cells, such as T cells, are the substances that actually attack and kill germs or other unhealthy substances, such as cancer cells.

What is Immunotherapy?

Melanoma is a type of skin cancer caused by damage to the DNA of melanocyte cells in the skin. Melanocytes produce melanin, a pigment in skin that is primarily responsible for skin color. When melanocytes DNA is damaged, it may cause the cells to mutate—leading to rapid, uncontrolled growth and the formation of malignant tumors. The goal of immunotherapy for cancer is to overcome these barriers to an effective anticancer immune response. These biological therapies restore or increase the activities of specific immune-system components or counteract immunosuppressive signals produced by cancer cells.
Photo by opensource.com

FDA approves new skin cancer drug for basal cell carcinoma

The U.S. Food and Drug Administration (FDA) has approved a new skin cancer drug designed to treat basal cell carcinoma. The drug, Odomzo, will be used to treat locally advanced basal cell carcinomas in patients where the disease has returned after the original tumor was surgically removed. The drug will also be an option for patients who are not candidates for surgery or radiation treatment.